


Ask a doctor about a prescription for AMLODIPINE/ATORVASTATIN KRKA 5 mg/10 mg FILM-COATED TABLETS
Patient Information Leaflet
Amlodipine/Atorvastatin Krka 5 mg/10 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Amlodipine/atorvastatin is used to prevent cardiovascular events (such as angina pectoris, heart attack) in patients with high blood pressure and who also have risk factors for cardiovascular disease, such as smoking, being overweight, high cholesterol levels in the blood, family history of heart disease, or diabetes. The presence of these risk factors associated with high blood pressure makes patients more likely to suffer cardiovascular events.
Amlodipine/atorvastatin is a product that contains two active substances, amlodipine (a calcium antagonist) and atorvastatin (a statin), and is used when your doctor considers it appropriate to take both medicines. Amlodipine is used to treat high blood pressure (hypertension) and atorvastatin reduces cholesterol levels.
High blood pressure (hypertension) is a disease in which blood pressure is permanently elevated abnormally and is one of the risk factors for suffering cardiovascular events (angina pectoris, heart attack, stroke).
Cholesterol is a substance that is naturally found in the body and is necessary for normal growth. However, if there is too much cholesterol in the blood, it can deposit on the walls of blood vessels, increasing the risk of blood clots forming and suffering cardiovascular events. This is one of the most common causes of heart disease.
Do not take Amlodipine/Atorvastatin Krka
Warnings and precautions
Consult your doctor or pharmacist before taking Amlodipine/Atorvastatin Krka
In any of these cases, your doctor will need to perform a blood test before and possibly during treatment with Amlodipine/Atorvastatin Krka to calculate the risk of muscle side effects. It is known that the risk of muscle side effects, e.g., rhabdomyolysis, increases when taken with certain medicines (see section 2 "Other medicines and Amlodipine/Atorvastatin Krka").
Also, inform your doctor or pharmacist if you experience constant muscle weakness. Additional tests and medicines may be necessary to diagnose and treat this problem.
While taking this medicine, your doctor will check if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugar and fat in the blood, are overweight, and have high blood pressure.
Children and adolescents
Amlodipine/Atorvastatin Krka is not recommended for use in children and adolescents.
Other medicines and Amlodipine/Atorvastatin Krka
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. There are some medicines that can interact with Amlodipine/Atorvastatin Krka. This interaction can mean that one or both medicines are less effective. It can also increase the risk or severity of side effects, including the important muscle damage known as rhabdomyolysis and myopathy (described in Section 4):
Amlodipine/Atorvastatin Krka may reduce your blood pressure even more if you are already taking other medicines to treat high blood pressure.
Tell your doctor or pharmacist if you are using or have recently used other medicines, including those bought without a prescription.
Taking Amlodipine/Atorvastatin Krka with food, drinks, and alcohol
Amlodipine/Atorvastatin Krka can be taken at any time of the day, with or without food.
Grapefruit juice
Do not drink more than one or two glasses of grapefruit juice per day because large amounts of grapefruit juice can alter the effects of Amlodipine/Atorvastatin Krka.
Alcohol
Avoid drinking too much alcohol while taking Amlodipine/Atorvastatin Krka. See the details in the "Warnings and precautions" section.
Pregnancy and breastfeeding
Do not take Amlodipine/Atorvastatin Krka if you are pregnant, breastfeeding, or trying to become pregnant. When taking Amlodipine/Atorvastatin Krka or any other medicine, women of childbearing age must take adequate contraceptive measures. Consult your doctor or pharmacist before using any medicine.
Driving and using machines
Do not drive or operate machinery if you feel dizzy after taking this medicine.
Amlodipine/Atorvastatin Krka contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again.
Adults
The usual initial dose of amlodipine/atorvastatin for adults is one 5 mg/10 mg tablet per day. If necessary, your doctor may increase the dose to one 10 mg/10 mg tablet per day.
Amlodipine/atorvastatin should be swallowed whole, with a little water. The tablets can be taken orally at any time of the day, with or without food. However, try to take your tablet at the same time every day.
Follow your doctor's dietary recommendations, especially regarding fat restriction in the diet, quitting smoking, and regular exercise.
If you think the effect of the amlodipine/atorvastatin tablets is too strong or too weak, tell your doctor or pharmacist.
Use in children and adolescents
This medicine is not recommended for children and adolescents.
If you take more Amlodipine/Atorvastatin Krka than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 915620420, indicating the medicine and the amount taken. Bring the remaining tablets, the package, and the complete box so that hospital staff can easily identify the medicine you have taken.
Excess fluid may accumulate in the lungs (pulmonary edema) causing difficulty breathing that can develop up to 24-48 hours after ingestion.
If you forget to take Amlodipine/Atorvastatin Krka
If you forget to take a dose, take the next scheduled dose at the correct time. Do not take a double dose to make up for forgotten doses.
If you stop taking Amlodipine/Atorvastatin Krka
Do not stop taking amlodipine/atorvastatin unless your doctor tells you to.
If you have any further questions on the use of this medicine or want to stop treatment, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If any of the following occur, stop taking Amlodipine/Atorvastatin Krka and inform your doctor immediately:
Very common adverse effects, which may affect more than 1 in 10 people, include:
Common adverse effects, which may affect up to 1 in 10 people, include:
Uncommon adverse effects, which may affect up to 1 in 100 people, include:
abnormal heart rhythm,
Rare adverse effects, which may affect up to 1 in 1,000 people, include:
Very rare adverse effects, which may affect up to 1 in 10,000 people, include:
Adverse effects of unknown frequency: the frequency cannot be estimated from the available data:
Consult your doctor if you experience weakness in the arms or legs that worsens after periods of activity, double vision, or drooping eyelids, difficulty swallowing, or difficulty breathing.
Reporting of Adverse Effects
If you experience any adverse effects, consult your doctor or pharmacist, even if they are possible adverse effects that are not listed in this leaflet. You can also report them directly through the Spanish Medicines Surveillance System for Human Use: http://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store above 30°C.
Store in the original packaging to protect it from moisture.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines in the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition of Amlodipine/Atorvastatin Krka
Core of the tablet
polysorbate 80, calcium carbonate, sodium croscarmellose, hydroxypropyl cellulose, microcrystalline cellulose, pregelatinized starch (from corn), magnesium stearate, and anhydrous colloidal silica. See section 2 "Amlodipine/Atorvastatin Krka contains sodium".
Coating
hypromellose (6 cp), titanium dioxide (E171), talc, and propylene glycol (E1520)
Appearance of the Product and Packaging Contents
The film-coated tablets of Amlodipine/Atorvastatin Krka 5 mg/10 mg are white, round, biconvex, film-coated tablets with beveled edges. Tablet dimensions: approximately 6 mm.
The tablets are available in boxes of 10, 14, 20, 28, 30, 50, 56, 60, 90, and 100 units, in blisters.
Not all pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
You can request more information about this medicine from the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
Member State | Medicine Name |
Slovenia | Amaloris 5 mg/10 mg film-coated tablets |
Bulgaria | Atordapin 5 mg/10 mg film-coated tablets |
Czech Republic | Atordapin 5 mg/10 mg |
Estonia | Amaloris |
Spain | Amlodipine/Atorvastatin Krka 5 mg/10 mg film-coated tablets EFG |
Hungary | Atordapin 5 mg/10 mg film tablet |
Lithuania | Atordapin 5 mg/10 mg coated tablets |
Latvia | Atordapin 5 mg/10 mg film-coated tablets |
Poland | Atordapin |
Portugal | Amlodipine + Atorvastatin Krka |
Romania | Atordapin 5 mg/10 mg film-coated tablets |
Slovakia | Atordapin 5 mg/10 mg film-coated tablets |
Date of the last revision of this leaflet:June 2023
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of AMLODIPINE/ATORVASTATIN KRKA 5 mg/10 mg FILM-COATED TABLETS in November, 2025 is around 13.24 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for AMLODIPINE/ATORVASTATIN KRKA 5 mg/10 mg FILM-COATED TABLETS – subject to medical assessment and local rules.